Desiderio J V, Kiener P A, Lin P F, Warr G A
Department of Microbiology, Bristol-Myers Co., Wallingford, Connecticut 06492.
Infect Immun. 1989 May;57(5):1615-7. doi: 10.1128/iai.57.5.1615-1617.1989.
Recombinant human tumor necrosis factor alpha (rHuTNF-alpha) administered intravenously to mice resulted in enhanced resistance to a lethal challenge infection of Listeria monocytogenes given 24 h later. The observed protection was lost following treatment of the rHuTNF-alpha preparations with rabbit polyclonal antibody rHuTNF-alpha but not with normal rabbit immunoglobulin G.
给小鼠静脉注射重组人肿瘤坏死因子α(rHuTNF-α)后,可增强其对24小时后给予的单核细胞增生李斯特菌致死性攻击感染的抵抗力。用兔多克隆抗体rHuTNF-α处理rHuTNF-α制剂后,观察到的保护作用消失,但用正常兔免疫球蛋白G处理则不会。